ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2020

Abstract Number: 1980

Understanding the Relationship Between Illness Perceptions and Self-Efficacy Among Latin Americans with SLE Through the Hablemos De Lupus Facebook Page

Erica Crosley1, Claudia Elera-Fitzcarrald2, Leandro Gabriel Ferreyra Garrot3, Yurilis Fuentes-Silva4, Soledad Ibañez5, Bernardo Pons-Estel6, Cristina Reátegui-Sokolova7 and Cristina Drenkard8, 1The Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Rheumatology. Hospital Nacional Guillermo Almenara Irigoyen. EsSalud; Universidad Científica del Sur, Lima, Peru, 3Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 4Universidad de Oriente, Ciudad Bolívar, Venezuela, 5Sanatorio Güemes, Buenos Aires, Argentina, 6Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Santa Fe, Argentina, 7Hospital Guillermo Almenara Irigoyen; Universidad San Ignacio de Loyola, Lima, Peru, 8Division of Rheumatology, Department of Medicine, Emory School of Medicine, Atlanta, GA

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2020

Keywords: Emotions, health behaviors, Minority Health, Surveys, Systemic lupus erythematosus (SLE)

Session Information

Date: Monday, November 9, 2020

Title: Patient Outcomes, Preferences, & Attitudes II: Engagement, Perceptions, & Quality of Life (1978–1982)

Session Type: Abstract Session

Session Time: 11:00AM-11:50AM

Background/Purpose: SLE disproportionately strikes Latinos, who are also at high risk for poor outcomes. Self-efficacy (SE) to manage chronic disease correlates with outcomes through self-management behavior. Illness perceptions (IP) are modifiable mental representations that vary among populations and may impact SE. This study aimed to explore IP and SE in this population and determine if one IP domain, emotional distress, increases the odds of low SE to manage symptoms. 

Methods: We collected self-reported measures through an anonymous survey posted on the Hablemos de Lupus (Let’s Talk about Lupus) education Facebook page (followed by 74,000 Spanish-speakers).  Participants were eligible if they were 18 or older, located in the American continent and self-reported a SLE diagnosis by a physician. The Brief Illness Perception Questionnaire (BIPQ) Likert scale was used to assess IP and the Patient Reported Outcomes Measurement Information System (PROMIS) to assess SE (to manage symptoms, treatment, emotions and social interactions). A higher BIPQ score (range 0-10) indicates more of the IP domain being measured, and a lower SE T-score indicates worse SE. We reported the mean score and SD of each BIPQ question; emotional distress IP was calculated using the average score of ‘worry’ and ‘emotional response’ questions. SE domains were reported as mean T-scores and SD, with the U.S. population with chronic illnesses as reference. Logistic regression was used to examine the association of emotional distress IP and low SE to manage symptoms (defined as a T-score ≤40) after controlling for confounders.

Results: There were 1401 eligible participants who started the survey and 100% completed. Participants were from 19 countries; ages 18-80; 95% females; 33% diagnosed in past 3 years; 46% reported renal, neurologic, vascular or pulmonary SLE manifestations, and 79% were under the care of a rheumatologist. Figures 1 and 2 depict mean IP and SE scores, with perceived emotional distress of 7.8 (SD 2.1). SE mean T-scores were lower than the reference population (T-score=50), ranging between 42.5 for managing emotions to 46.3 for treatment and symptom management (Figure 2). Per 1-unit increase of emotional distress the OR of low SE to manage symptoms was 1.44 [95% CI 1.29-1.61], after controlling for covariates (Table). Lack of social support and recent diagnosis were independently associated with low SE to manage symptoms in the multivariate model (Table).

Conclusion: Our findings underscore high illness-related emotional distress in Latinos with SLE, despite reporting relatively high understanding of SLE and its treatment. Moreover, SE levels in Latinos with SLE were below the average U.S. population across multiple domains. We found that those who perceive SLE as more emotionally distressing had lower SE to manage symptoms, suggesting that emotional illness perception may be a promising target for Latino SLE interventions. Our data also suggest that patients recently diagnosed or lacking social support may benefit from SE interventions. Education to modify perceived SLE emotional distress may improve SE to manage symptoms among Latino patients, potentially contributing to better patient-centered and clinical outcomes in this population.


Disclosure: E. Crosley, Lupus Foundation of America, 2; C. Elera-Fitzcarrald, None; L. Ferreyra Garrot, None; Y. Fuentes-Silva, None; S. Ibañez, None; B. Pons-Estel, None; C. Reátegui-Sokolova, Janssen, 2; C. Drenkard, None.

To cite this abstract in AMA style:

Crosley E, Elera-Fitzcarrald C, Ferreyra Garrot L, Fuentes-Silva Y, Ibañez S, Pons-Estel B, Reátegui-Sokolova C, Drenkard C. Understanding the Relationship Between Illness Perceptions and Self-Efficacy Among Latin Americans with SLE Through the Hablemos De Lupus Facebook Page [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/understanding-the-relationship-between-illness-perceptions-and-self-efficacy-among-latin-americans-with-sle-through-the-hablemos-de-lupus-facebook-page/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/understanding-the-relationship-between-illness-perceptions-and-self-efficacy-among-latin-americans-with-sle-through-the-hablemos-de-lupus-facebook-page/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology